Contrast-Induced Nephropathy: A Fact or Fiction in Lower Limb Revascularization?

被引:5
作者
Martinez-Rico, Carlos [1 ,2 ]
Marti-Mestre, Xavier [1 ,2 ]
Romera-Villegas, Antonio [1 ,2 ]
Espinar-Garcia, Emma [1 ,2 ]
Iborra-Ortega, Elena [1 ,2 ]
Vila-Coll, Ramon [1 ,2 ]
机构
[1] Hosp Univ Bellvitge, Dept Endovasc & Vasc Surg, Barcelona, Spain
[2] Inst Invest Biomed Bellvitge, IDIBELL, Barcelona, Spain
关键词
PERCUTANEOUS CORONARY INTERVENTION; SALINE HYDRATION; N-ACETYLCYSTEINE; ASCORBIC-ACID; ANGIOPLASTY; ANGIOGRAPHY; PREVENTION;
D O I
10.1016/j.avsg.2017.03.193
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Contrast-induced nephropathy (CIN) is defined as an increase >25% of serum creatinine from baseline, occurring in 24-48 hours after exposure to contrast, while alternative explanations for renal impairment have been excluded. The volume administered directly relates to risk, increasing by 12% per 100 mL of contrast. According to the series, its incidence varies between 3.3% and 8% in patients without renal damage and 12-50% in patients with chronic kidney disease (CKD) and/or diabetes mellitus (DM). The purpose of this study is to determine the incidence of CIN in endovascular revascularization of lower limbs in our center, where we apply the ALARA concept (As Low As Reasonably Achievable) to the use of contrast. Material and Methods: 163 patients who underwent endovascular revascularization procedures in lower limbs were included in this prospective observational study between February 2013 and April 2015. They were classified according to clinical stage and presence of DM and/or CKD. Data included serum creatinine values preoperative and postoperative, type and volume of contrast used. Patients on hemodialysis and those without sufficient analytical data were excluded. Chi-squared test and Student t-test were used for data analysis. P < 0.05 was considered statistically significant. Results: 109 patients were enrolled, with 67% of DM and 31.5% of CKD. CIN incidence was 3.7% in patients without DM neither CKD, in DM was 6.8% and 12.5% in CKD. Mean creatinine presurgery was 97.96 and postsurgery 97.07, finding no significant differences between them (P = 0.753). Medium-contrast volume was 37.43 mL +/- 22.3. The worsening variable (creatinine postsurgery minus creatinine presurgery) was evaluated according to clinical stage, DM, or CKD, being not significant in either group. Conclusions: In our experience, the dose administered of contrast was not related to the existence of postprocedure CIN, due to the policy of optimizing the use of contrast.
引用
收藏
页码:277 / 281
页数:5
相关论文
共 18 条
  • [1] Efficacy of Ascorbic Acid, N-Acetylcysteine, or Combination of Both on Top of Saline Hydration versus Saline Hydration Alone on Prevention of Contrast-Induced Nephropathy: A Prospective Randomized Study
    Albabtain, Monirah A.
    Almasood, Ali
    Alshurafah, Hytham
    Alamri, Hussain
    Tamim, Hani
    [J]. JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2013, 26 (01) : 90 - 96
  • [2] [Anonymous], Ejection fraction heart failure measurement
  • [3] Preventing nephropathy induced by contrast medium
    Barrett, BJ
    Parfrey, PS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (04) : 379 - 386
  • [4] DOSING OF CONTRAST MATERIAL TO PREVENT CONTRAST NEPHROPATHY IN PATIENTS WITH RENAL-DISEASE
    CIGARROA, RG
    LANGE, RA
    WILLIAMS, RH
    HILLIS, LD
    [J]. AMERICAN JOURNAL OF MEDICINE, 1989, 86 (06) : 649 - 652
  • [5] Duan NN, 2015, MED SCI MONITOR, V21, P292, DOI 10.12659/MSM.892446
  • [6] Contrast-induced nephropathy: Pharmacology, pathophysiology and prevention
    Geenen R.W.F.
    Kingma H.J.
    van der Molen A.J.
    [J]. Insights into Imaging, 2013, 4 (6) : 811 - 820
  • [7] Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    Go, AS
    Chertow, GM
    Fan, DJ
    McCulloch, CE
    Hsu, CY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) : 1296 - 1305
  • [8] A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system
    Harjai, Kishore J.
    Ralzada, Amol
    Shenoy, Chetan
    Sattur, Sudhakar
    Orshaw, Pamela
    Yaeger, Karl
    Boura, Judy
    Aboufares, Ali
    Sporn, Daniel
    Stapleton, Dwight
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (06) : 812 - 819
  • [9] N-acetylcysteine versus AScorbic acid for Preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography: NASPI study-a prospective randomized controlled trial
    Jo, Sang-Ho
    Koo, Bon-Kwon
    Park, Jin-Shik
    Kang, Hyun-Jae
    Kim, Yong-Jin
    Kim, Hack-Lyoung
    Chae, In-Ho
    Choi, Dong-Ju
    Sohn, Dae-Won
    Oh, Byung-Hee
    Park, Young-Bae
    Choi, Yun-Shik
    Kim, Hyo-Soo
    [J]. AMERICAN HEART JOURNAL, 2009, 157 (03) : 576 - 583
  • [10] Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, Kidney Int Suppl, V3, P1, DOI DOI 10.1038/KISUP.2012.73